The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metabolic profiling of antiangiogenic agents on glioma cells.
Antoine F Carpentier
Consultant or Advisory Role - Roche
Tanja Mesti
Honoraria - Roche
Claire Banissi
No relevant relationships to disclose
Philippe Savarin
No relevant relationships to disclose
Mohamed N Triba
No relevant relationships to disclose
Janja Ocvirk
Honoraria - Roche